Given the carcinogenic properties of endogenous estrogens, reducing their levels in the body by inhibition of steroidogenic enzymes such as Cyp19 and HSD would protect against breast cancer development (Figure 2; Appendix 1). This evidence concerns the gene CYP19A1 and breast cancer.